Health News Releases

  • Today May 2
Martin Steinhart, CEO, AOP Health; Copyright: AOP Health/Studio Koekart
December 14, 2023 12:10
AOP Health Receives Market Authorization for Landiolol in Canada
At the end of November 2023, AOP Orphan Pharmaceuticals GmbH (AOP Health), an Austrian pharmaceutical company based in Vienna, received authorization from the Canadian Health Authority (Health Canada)
December 13, 2023 11:10
Forge Biologics Announces Publication in Human Gene Therapy on a Novel Finding That Changes a Fundamental Understanding of AAV Production
Forge Biologics (Forge), a leading manufacturer of genetic medicines, announced today the peer-reviewed publication of, “A novel role for the adenovirus L4 region 22K and 33K proteins in adeno-associa
Masimo Root® with ORi™ (Photo: Business Wire)
December 12, 2023 16:30
New Study Finds Significant Correlation Between Masimo ORi™ and Arterial Partial Pressure of Oxygen During One-Lung Ventilation
Masimo (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.masimo.com&esheet=53868764&newsitemid=20231210873994&lan=en-US&anchor=Masimo&index=1&md5=6909e6cf722103d0ab237709071a118c)(
December 12, 2023 14:09
BIO KOREA 2024: Registration Now Open for Programs and Booths
BIO KOREA 2024 (https://www.biokorea.org/index.asp?pLn=Eng), jointly hosted by the Korea Health Industry Development Institute (KHIDI, President: Cha Soon-do) and Chungcheongbuk-do (Governor: Kim Youn
Ferring and PharmaBiome Enter Into a New Microbiome R&D Collaboration and Exclusive Licensing Agreement
December 11, 2023 16:00
Ferring and PharmaBiome Enter Into a New Microbiome R&D Collaboration and Exclusive Licensing Agreement
Ferring Pharmaceuticals and Zürich-based microbiome translation company PharmaBiome are today announcing a research and development collaboration to drive forward new microbiome-based biotherapeutics
“The incidence of breast cancer in women is seeing an upward trend in the world, and today we can sa
December 08, 2023 16:10
World Renowned Cancer Researchers From Spain and U.S. Join Forces to Address Critical Needs and Challenges in Women’s Cancer Research
Mary Kay Inc. (https://marykayglobal.com/), the world's No. 1 direct selling skin care and color cosmetics brand[1] and its company-sponsored foundations, including the Mary Kay Ash Foundation (https:
Professor Heinz Gisslinger, MedUni Vienna/Austria (Fotocredit: IntMedCom)
December 08, 2023 14:15
Blood Cancer: AOP Health Announces New Findings in Patients With Polycythemia Vera to Be Presented at the American Society of Hematology (ASH) 65th Annual Meeting
AOP Orphan Pharmaceuticals GmbH (AOP Health), Vienna, Austria, announced the results of an analysis assessing the impact of an individually optimized dosing regimen of ropeginterferon alfa-2b on treat
December 07, 2023 14:30
ReNAgade Therapeutics Appoints Paul Perreault to Board of Directors
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced the appointment of Paul Perreault to its Board of Directors, effective December 5, 2023. Mr. Perre
December 07, 2023 11:20
PDC*line Pharma Completes Enrolment of Four Cohorts of Patients in PDC-LUNG-101 Phase I/II Clinical Trial
PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active immunotherapies for cancers, today announces completion of enrolment of the fourth cohort of pati
December 06, 2023 13:45
Merck Provides Update on Phase III Results for Evobrutinib in Relapsing Multiple Sclerosis
Merck, a leading science and technology company, today announced that its two Phase III EVOLUTION clinical trials (evolutionRMS 1 and evolutionRMS 2) investigating the efficacy and safety of evobrutin
December 06, 2023 10:45
Takeda and The New York Academy of Sciences Announce 2024 Innovators in Science Award Winners
Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) and The New York Academy of Sciences today announced the winners of the 2024 Innovators in Science Award for their excellence in
QPS Missouri is a division of QPS Holdings, LLC, a global Contract Research Organization. QPS Missou
December 05, 2023 10:35
QPS Holdings, LLC Expands Operations in Springfield, Missouri
QPS Holdings, LLC, a global contract research organization has expanded operations in Springfield, Missouri. The new facilities include a clinical (safety) laboratory, an updated self-contained pharma
Stand Tall in the face of disaster with IFRC-DREF Insurance. (Photo: Business Wire)
December 05, 2023 10:25
IFRC-DREF calls on global donors to help the world ‘Stand Tall’ in the face of accelerating humanitarian need - supporting smarter and faster disaster relief
The International Federation of Red Cross and Red Crescent Societies (IFRC (https://www.ifrc.org/)) has launched a new campaign to address rapidly escalating climate driven humanitarian crises. It cal
December 05, 2023 10:10
Merck Strengthens Oncology Portfolio Through Commercialization Agreement With Abbisko for Phase III Asset, Pimicotinib
Merck, a leading science and technology company, today announced a license agreement with Abbisko Therapeutics Co. Ltd., Shanghai, China, for pimicotinib (ABSK021), which is currently being evaluated
Ultra-low temperature freezer farm units at Mach 2 Pharmafreight’s Netherlands facility. (Photo: Bus
December 05, 2023 09:50
AIT Worldwide Logistics acquires European life sciences specialist Mach II Shipping Ltd
AIT Worldwide Logistics, a global supply chain solutions leader, has acquired Mach II Shipping Ltd, a U.K.-based freight forwarder specializing in worldwide distribution of pharmaceuticals and related
December 04, 2023 15:30
Global donors pledge over US$777 million to defeat neglected tropical diseases and improve the lives of 1.6 billion people at the Reaching the Last Mile Forum at COP28
Global donors at the 2023 Reaching the Last Mile Forum today pledged a collective US$777.2 million to help control, eliminate, and eradicate neglected tropical diseases (NTDs), in a landmark push to a
Expand businesses into growing markets in the APAC region with Healthcare+ Expo Taiwan. Join medical
December 04, 2023 14:15
Beyond Medtech: Healthcare+ Expo Taiwan Sets New Stage for Global Innovation in Future AI Healthcare
The Healthcare+ Expo Taiwan, currently taking place at Nangang Exhibition Hall 1 from November 30 to December 3, 2023, is poised to redefine the landscape of AI healthcare on a global scale. This year
QPS Neuropharmacology facility in Grambach, Austria. (Graphic: Business Wire)
December 01, 2023 13:10
QPS Holdings, LLC divests its Neuropharmacology Business Unit
Today QPS Holdings, LLC (QPS) a leading drug development Contract Research Organization (CRO), announces an agreement to sell its Neuropharmacology business unit (QPS Neuropharmacology) to Scantox, a
December 01, 2023 11:50
Fujirebio and Sysmex Expand CDMO Partnership into the Field of Neurodegenerative Diseases under Their Immunoassay Collaboration
Fujirebio Holdings, Inc. (President & CEO: Goki Ishikawa) and Sysmex Corporation (President: Kaoru Asano) today announced that they have entered into an agreement to expand their Contract Development
November 30, 2023 15:36
Results From Galderma’s Phase IIIb Trials Demonstrate Rapid and Long-Lasting Effect of RelabotulinumtoxinA on Crow’s Feet and Frown Lines
Galderma announced today topline results from two phase IIIb trials investigating RelabotulinumtoxinA for the treatment of glabellar lines (GL - frown lines) and lateral canthal lines (LCL - crow’s fe
November 30, 2023 15:15
ReValve Solutions Announces Successful First-in-Human with Next Generation TMVR Technology
ReValve Solutions Inc. (ReValve), which has developed a next generation technology for Transcatheter Mitral Valve Replacement (TMVR), announced that an 81-year-old male, with a history of heart failur
Discover the opportunities and challenges for medical practice leaders in evaluating their platforms
November 29, 2023 13:50
Healthcare Leaders Cite Automation, Worker Burnout as Top Drivers of Technology Integrations, MGMA and Laserfiche Study Finds
New research by Medical Group Management Association (MGMA) and Laserfiche (https://www.laserfiche.com/?utm_content=mgma2023&utm_campaign=healthcare) — the leading SaaS provider of intelligent content
November 29, 2023 11:50
Kenvue to Participate in the Morgan Stanley Global Consumer & Retail Conference on December 6, 2023
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced the company’s participation in Morgan Stanley’s Global Consumer & Retail Conferen
Figure 1: Area of health concern (Graphic: Business Wire)
November 28, 2023 13:20
Kirin iMUSE Immune Care and Healthya Visceral Fat Down will go on sale on Tuesday, November 28!
Kirin Holdings Company, Limited (TOKYO:2503) will launch a dual-care functional food supplement Kirin iMUSE Immuno-Care and Healthya Visceral Fat Down on November 28 (Tuesday). This product is a colla
APR Corp.
November 27, 2023 09:00
APR Achieves Consolidated Sales of KRW 122 Billion and Consolidated Operating Profit of KRW 21.7 Billion in Q3 2023
APR Corp. (https://www.apr-in.com/) (APR, CEO: Byunghoon Kim), a global beauty tech company, broke its record-high performance in Q3 2023. APR disclosed on November 14 that it had consolidated sal
25 per page50 per page75 per page100 per page